(Q34655075)

3 August 2017

1 reference

title

Endothelial dysfunction in insulin resistance and type 2 diabetes (English)

1 reference

3 August 2017

0 references

0 references

1 reference

1 reference

Jansson PA

1

1 reference

PubMed ID

17645585

3 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

Journal of Internal Medicine

3 August 2017

1 reference

3 August 2017

262

1 reference

3 August 2017

173-183

1 reference

3 August 2017

2

1 reference

Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes.

3 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Fundamentals of endothelial function for the clinical cardiologist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Vascular complications in diabetes mellitus: the role of endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Diabetes and endothelial dysfunction: a clinical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Type 2 diabetes as a lipid disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Family history of diabetes is a major determinant of endothelial function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Gq/G13 signaling by ET-1 in smooth muscle: MYPT1 phosphorylation via ETA and CPI-17 dephosphorylation via ETB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Endocrine and signalling role of adipose tissue: new perspectives on fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

The dysregulated adipose tissue: a connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Adiponectin and adiponectin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Adiponectin and cardiovascular disease: state of the art?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Resistin is an inflammatory marker of atherosclerosis in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Endothelium-dependent flow-mediated vasodilatation, insulin resistance and the metabolic syndrome in 60-year-old men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Insulin resistance and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

New Markers of Inflammation and Endothelial Cell Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Biomarkers of vascular disease linking inflammation to endothelial activation: Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Insulin-induced vasodilatation: physiology or pharmacology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Direct measurements of the permeability surface area for insulin and glucose in human skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Low adipocyte IRS-1 protein expression is associated with an increased arterial stiffness in non-diabetic males

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Adipose tissue, inflammation, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

IL-1-induced NFkappa B and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Tumor necrosis factor-alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

C-reactive protein: risk marker or mediator in atherothrombosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Endothelial inflammation in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Endothelin-1 impairs glucose transporter trafficking via a membrane-based mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Physiology and pathophysiology of the adipose tissue renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Ramipril and the development of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Cross-talk between the insulin and angiotensin signaling systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Delayed transcapillary transport of insulin to muscle interstitial fluid in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Endothelial-dependent vasodilation and incidence of type 2 diabetes in a population of healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

Elevated Markers of Endothelial Dysfunction Predict Type 2 Diabetes Mellitus in Middle-Aged Men and Women From the General Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2007.01830.X

10.1111/J.1365-2796.2007.01830.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

17645585